{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T14:20:19Z","timestamp":1787926819424,"version":"build-2784847793"},"reference-count":38,"publisher":"China Science Publishing & Media Ltd.","issue":"8","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2025,8,1]]},"DOI":"10.3724\/abbs.2024221","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T04:43:39Z","timestamp":1732769019000},"page":"1260-1269","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":5,"title":["<italic>NCOA6<\/italic> knockdown enhances RSL3-induced ferroptosis in pancreatic cancer cells and increases the sensitivity to gemcitabine"],"prefix":"10.3724","volume":"57","author":[{"given":"Yuming","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guixiong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuhan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/ijc.11679","volume":"109","author":"Schniewind B","year":"2004","unstructured":"Schniewind B, Christgen M, Kurdow R, Haye S, Kremer B, Kalthoff H, Ungefroren H. Resistance of pancreatic cancer to gemcitabine treatment is dependent on mitochondria-mediated apoptosis. Intl J Cancer, 2004, 109: 182-188.","journal-title":"Intl J Cancer"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s11306-018-1452-7","volume":"14","author":"Gebregiworgis T","year":"2018","unstructured":"Gebregiworgis T, Bhinderwala F, Purohit V, Chaika NV, Singh PK, Powers R. Insights into gemcitabine resistance and the potential for therapeutic monitoring. Metabolomics, 2018, 14:","journal-title":"Metabolomics"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"Dixon SJ","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell, 2012, 149: 1060-1072.","journal-title":"Cell"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"Yang WS","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, Cheah JH. Regulation of ferroptotic cancer cell death by GPX4. Cell, 2014, 156: 317-331.","journal-title":"Cell"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"nrs.06002","DOI":"10.1621\/nrs.06002","volume":"6","author":"Mahajan MA","year":"2008","unstructured":"Mahajan MA, Samuels HH. Nuclear receptor coactivator\/coregulator NCoA6(NRC) is a pleiotropic coregulator involved in transcription, cell survival, growth and development. Nucl Recept Signal, 2008, 6:","journal-title":"Nucl Recept Signal"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"4994","DOI":"10.1128\/MCB.24.11.4994-5004.2004","volume":"24","author":"Mahajan MA","year":"2004","unstructured":"Mahajan MA, Das S, Zhu H, Tomic-Canic M, Samuels HH. The nuclear hormone receptor coactivator NRC is a pleiotropic modulator affecting growth, development, apoptosis, reproduction, and wound repair. Mol Cell Biol, 2004, 24: 4994-5004.","journal-title":"Mol Cell Biol"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"4480","DOI":"10.3748\/wjg.v23.i25.4480","volume":"23","author":"Triki M","year":"2017","unstructured":"Triki M, Lapierre M, Cavailles V, Mokdad-Gargouri R. Expression and role of nuclear receptor coregulators in colorectal cancer. World J Gastroenterol, 2017, 23: 4480-4490.","journal-title":"World J Gastroenterol"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/gcc.10122","volume":"35","author":"Mahlam\u00e4ki EH","year":"2002","unstructured":"Mahlam\u00e4ki EH, B\u00e4rlund M, Tanner M, Gorunova L, H\u00f6glund M, Karhu R, Kallioniemi A. Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer. Genes Chromosomes Cancer, 2002, 35: 353-358.","journal-title":"Genes Chromosomes Cancer"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1158\/1078-0432.612.11.2","volume":"11","author":"Yang SH","year":"2005","unstructured":"Yang SH, Seo MY, Jeong HJ, Jeung HC, Shin J, Kim SC, Noh SH. Gene copy number change events at chromosome 20 and their association with recurrence in gastric cancer patients. Clin Cancer Res, 2005, 11: 612-620.","journal-title":"Clin Cancer Res"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1158\/1055-9965.EPI-14-1426","volume":"24","author":"Gibbs DC","year":"2015","unstructured":"Gibbs DC, Orlow I, Kanetsky PA, Luo L, Kricker A, Armstrong BK, Anton-Culver H. Inherited genetic variants associated with occurrence of multiple primary melanoma. Cancer Epidemiol Biomarkers Prevention, 2015, 24: 992-997.","journal-title":"Cancer Epidemiol Biomarkers Prevention"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1093\/bioinformatics\/btt191","volume":"29","author":"Srihari S","year":"2013","unstructured":"Srihari S, Ragan MA. Systematic tracking of dysregulated modules identifies novel genes in cancer. Bioinformatics, 2013, 29: 1553-1561.","journal-title":"Bioinformatics"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"e12876","DOI":"10.1111\/cpr.12876","volume":"53","author":"Wu L","year":"2020","unstructured":"Wu L, Zhao KQ, Wang W, Cui LL, Hu LL, Jiang XX, Shuai J. Nuclear receptor coactivator 6 promotes HTR-8\/SVneo cell invasion and migration by activating NF-\u039ab-mediated MMP9 transcription. Cell Prolif, 2020, 53:","journal-title":"Cell Prolif"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/cas.15577","volume":"114","author":"Fang Y","year":"2023","unstructured":"Fang Y, Xu Y, Liao W, Ji T, Yu L, Li L, Pan M. Multiomics analyses and machine learning of nuclear receptor coactivator 6 reveal its essential role in hepatocellular carcinoma. Cancer Sci, 2023, 114: 75-90.","journal-title":"Cancer Sci"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.canlet.2019.03.024","volume":"452","author":"Hu Q","year":"2019","unstructured":"Hu Q, Qin Y, Ji S, Xu W, Liu W, Sun Q, Zhang Z. UHRF1 promotes aerobic glycolysis and proliferation via suppression of SIRT4 in pancreatic cancer. Cancer Lett, 2019, 452: 226-236.","journal-title":"Cancer Lett"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"Doll S","year":"2017","unstructured":"Doll S, Proneth B, Tyurina YY, Panzilius E, Kobayashi S, Ingold I, Irmler M. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol, 2017, 13: 91-98.","journal-title":"Nat Chem Biol"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"108487","DOI":"10.1016\/j.celrep.2020.108487","volume":"33","author":"Zhao Y","year":"2020","unstructured":"Zhao Y, Li M, Yao X, Fei Y, Lin Z, Li Z, Cai K. HCAR1\/MCT1 regulates tumor ferroptosis through the lactate-mediated AMPK-SCD1 activity and its therapeutic implications. Cell Rep, 2020, 33:","journal-title":"Cell Rep"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.canlet.2020.12.019","volume":"502","author":"Chen J","year":"2021","unstructured":"Chen J, Ding C, Chen Y, Hu W, Yu C, Peng C, Feng X. ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc\/SREBP1 pathway. Cancer Lett, 2021, 502: 154-165.","journal-title":"Cancer Lett"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.1007\/s13277-015-3047-5","volume":"36","author":"Sun Y","year":"2015","unstructured":"Sun Y, He W, Luo M, Zhou Y, Chang G, Ren W, Wu K. SREBP1 regulates tumorigenesis and prognosis of pancreatic cancer through targeting lipid metabolism. Tumor Biol, 2015, 36: 4133-4141.","journal-title":"Tumor Biol"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"5355","DOI":"10.1158\/0008-5472.CAN-19-0369","volume":"79","author":"Tesfay L","year":"2019","unstructured":"Tesfay L, Paul BT, Konstorum A, Deng Z, Cox AO, Lee J, Furdui CM. Stearoyl-CoA desaturase 1 protects ovarian cancer cells from ferroptotic cell death. Cancer Res, 2019, 79: 5355-5366.","journal-title":"Cancer Res"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"RE13","DOI":"10.1126\/stke.2502004re13","volume":"2004","author":"Colicelli J","year":"2004","unstructured":"Colicelli J. Human RAS superfamily proteins and related gtPases. Sci STKE, 2004, 2004:","journal-title":"Sci STKE"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1242\/jcs.01660","volume":"118","author":"Wennerberg K","year":"2005","unstructured":"Wennerberg K, Rossman KL, Der CJ. The Ras superfamily at a glance. J Cell Sci, 2005, 118: 843-846.","journal-title":"J Cell Sci"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S1535-6108(03)00050-3","volume":"3","author":"Dolma S","year":"2003","unstructured":"Dolma S, Lessnick SL, Hahn WC, Stockwell BR. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell, 2003, 3: 285-296.","journal-title":"Cancer Cell"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.chembiol.2008.02.010","volume":"15","author":"Yang WS","year":"2008","unstructured":"Yang WS, Stockwell BR. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem Biol, 2008, 15: 234-245.","journal-title":"Chem Biol"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3233\/JAD-130137","volume":"35","author":"Aso E","year":"2013","unstructured":"Aso E, Juv\u00e9s S, Maldonado R, Ferrer I. CB2 cannabinoid receptor agonist ameliorates alzheimer-like phenotype in A\u03b2PP\/PS1 mice. J Alzheimer Dis, 2013, 35: 847-858.","journal-title":"J Alzheimer Dis"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.taap.2011.11.005","volume":"258","author":"Singh UP","year":"2012","unstructured":"Singh UP, Singh NP, Singh B, Price RL, Nagarkatti M, Nagarkatti PS. Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10\u2013\/\u2013 mice by attenuating the activation of T cells and promoting their apoptosis. Toxicol Appl Pharmacol, 2012, 258: 256-267.","journal-title":"Toxicol Appl Pharmacol"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1016\/j.neurobiolaging.2013.05.027","volume":"34","author":"Stumm C","year":"2013","unstructured":"Stumm C, Hiebel C, Hanstein R, Purrio M, Nagel H, Conrad A, Lutz B. Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer\u2032s disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition. Neurobiol Aging, 2013, 34: 2574-2584.","journal-title":"Neurobiol Aging"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nchembio.2238","volume":"13","author":"Kagan VE","year":"2017","unstructured":"Kagan VE, Mao G, Qu F, Angeli JPF, Doll S, Croix CS, Dar HH. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol, 2017, 13: 81-90.","journal-title":"Nat Chem Biol"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.chembiol.2019.03.001","volume":"26","author":"Das UN","year":"2019","unstructured":"Das UN. Saturated fatty acids, MUFAs and PUFAs regulate ferroptosis. Cell Chem Biol, 2019, 26: 309-311.","journal-title":"Cell Chem Biol"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1172\/JCI61462","volume":"122","author":"Zhao X","year":"2012","unstructured":"Zhao X, Feng D, Wang Q, Abdulla A, Xie XJ, Zhou J, Sun Y. Regulation of lipogenesis by cyclin-dependent kinase 8-mediated control of SREBP-1. J Clin Invest, 2012, 122: 2417-2427.","journal-title":"J Clin Invest"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.4161\/cc.20811","volume":"11","author":"Li W","year":"2012","unstructured":"Li W, Tai Y, Zhou J, Gu W, Bai Z, Zhou T, Zhong Z. Repression of endometrial tumor growth by targeting SREBP1 and lipogenesis. Cell Cycle, 2012, 11: 2348-2358.","journal-title":"Cell Cycle"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","volume":"551","author":"Hangauer MJ","year":"2017","unstructured":"Hangauer MJ, Viswanathan VS, Ryan MJ, Bole D, Eaton JK, Matov A, Galeas J. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Nature, 2017, 551: 247-250.","journal-title":"Nature"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/cbin.11121","volume":"43","author":"Liu Q","year":"2019","unstructured":"Liu Q, Wang K. The induction of ferroptosis by impairing STAT3\/Nrf2\/GPx4 signaling enhances the sensitivity of osteosarcoma cells to cisplatin. Cell Biol Int, 2019, 43: 1245-1256.","journal-title":"Cell Biol Int"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.21037\/atm-20-2554a","volume":"8","author":"Tang R","year":"2020","unstructured":"Tang R, Hua J, Xu J, Liang C, Meng Q, Liu J, Zhang B. The role of ferroptosis regulators in the prognosis, immune activity and gemcitabine resistance of pancreatic cancer. Ann Transl Med, 2020, 8:","journal-title":"Ann Transl Med"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"100916","DOI":"10.1016\/j.drup.2022.100916","volume":"66","author":"Wang Y","year":"2023","unstructured":"Wang Y, Wu X, Ren Z, Li Y, Zou W, Chen J, Wang H. Overcoming cancer chemotherapy resistance by the induction of ferroptosis. Drug Resist Updat, 2023, 66:","journal-title":"Drug Resist Updat"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.3390\/cancers14133152","volume":"14","author":"Yang H","year":"2022","unstructured":"Yang H, Liu B, Liu D, Yang Z, Zhang S, Xu P, Xing Y. Genome-wide CRISPR screening identifies dCK and CCNL1 as genes that contribute to gemcitabine resistance in pancreatic cancer. Cancers, 2022, 14:","journal-title":"Cancers"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"8482","DOI":"10.3748\/wjg.v20.i26.8482","volume":"20","author":"Nordh S","year":"2014","unstructured":"Nordh S. hENT1 expression is predictive of gemcitabine outcome in pancreatic cancer: a systematic review. World J Gastroenterol, 2014, 20:","journal-title":"World J Gastroenterol"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"4731","DOI":"10.1200\/JCO.2006.06.1101","volume":"24","author":"Bepler G","year":"2006","unstructured":"Bepler G, Kusmartseva I, Sharma S, Gautam A, Cantor A, Sharma A, Simon G. RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancer. J Clin Oncol, 2006, 24: 4731-4737.","journal-title":"J Clin Oncol"},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"BSR20181374","DOI":"10.1042\/BSR20181374","volume":"39","author":"Lu H","year":"2019","unstructured":"Lu H, Lu S, Yang D, Zhang L, Ye J, Li M, Hu W. MiR-20a-5p regulates gemcitabine chemosensitivity by targeting RRM2 in pancreatic cancer cells and serves as a predictor for gemcitabine-based chemotherapy. Biosci Rep, 2019, 39:","journal-title":"Biosci Rep"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.sciengine.com\/doi\/pdf\/69C4161ADC2E4DB091B04D798BAC4ABD","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2024221","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/pdf\/69C4161ADC2E4DB091B04D798BAC4ABD","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T03:19:00Z","timestamp":1757647140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2024221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":38,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,3,10]]},"published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.3724\/abbs.2024221","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,10]]}}}